Dr. Sven Kili, MD, PhD
Cell & Gene Therapy Senior Leader
Dr. Kili has a strong track record of success in developing and commercialising innovative advanced therapies. Dr. Kili’s focus is utilising a commercially-minded and pragmatic approach to advanced therapy development, he has supported a number of programs through clinical development (phase II/ III/ IV), product registration and reimbursement activities. Dr. Kili is also a pharmaceutical physician and clinician who has extensive surgical and medical clinical experience with a strong patient focus.